Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.5M | $12.2M | $10.9M | $12.7M | $13.9M | $11.0M | $13,599.084 | $13.4M | $13.0M | $10.8M | $14.0M | $13.4M | $15.4M | $13.8M | $14.3M | $13.7M |
| Research & development | $463,644 | $456,779 | $463,992 | $490,770 | $478,642 | $451,208 | $397,391 | $399,517 | $646,079 | $651,828 | $648,211 | $730,412 | $717,000 | $693,000 | $637,000 | — |
| Operating expenses | $2.4M | $2.4M | $2.1M | $2.2M | $2.0M | $2.0M | $2.1M | $2.1M | $1.8M | $1.9M | $1.9M | $1.9M | $2.5M | $2.5M | $2.6M | $2.6M |
| Operating income | $2.2M | $3.6M | $2.9M | $4.0M | $5.7M | $3.6M | $5.4M | $5.6M | $5.2M | $3.4M | $6.3M | $5.5M | $7.3M | $6.1M | $6.1M | $5.1M |
| EBITDAderived | $2.4M | $3.7M | $3.0M | $4.2M | $5.8M | $3.8M | $5.6M | $5.8M | $5.4M | $3.6M | $6.5M | $5.7M | $7.5M | $6.4M | $6.4M | $5.3M |
| Net income | $2.1M | $3.3M | $2.6M | $2.6M | $4.7M | $3.3M | $4.8M | $4.4M | $3.8M | $2.6M | $4.6M | $4.1M | $5.9M | $4.8M | $4.7M | $3.8M |
| Basic EPSper diluted share | $0.46 | $0.71 | $0.56 | $0.56 | $1.01 | $0.72 | $1.04 | $0.95 | $0.84 | $0.56 | $1.00 | $0.88 | $1.28 | $1.05 | $1.03 | $0.80 |
| Diluted EPSper diluted share | — | — | — | — | $1.01 | $0.72 | $1.04 | $0.95 | $0.84 | $0.56 | $1.00 | $0.88 | $1.28 | $1.05 | $1.03 | $0.80 |